Results 221 to 230 of about 1,615,665 (249)
Some of the next articles are maybe not open access.
Epoprostenol in pulmonary arterial hypertension
Expert Opinion on Drug Metabolism & Toxicology, 2008Pulmonary arterial hypertension (PAH) is a devastating disease leading to right heart failure and death in a relatively young patient population. In recent years novel PAH specific therapies have become available.To determine the place of epoprostenol in current PAH treatment strategies.An extensive Medline search was performed to evaluate the use of ...
Jacobs, W., Vonk Noordegraaf, A.
openaire +3 more sources
Sildenafil for Pulmonary Arterial Hypertension
American Journal of Therapeutics, 2019Pulmonary hypertension is a life-threatening illness with debilitating physical and emotional consequences. The progression of this devastating disease is characterized by a continuous increase in pulmonary vascular resistance, which results in elevated pulmonary artery pressure and leads to right heart failure.
Bhogal, Sukhdeep +5 more
openaire +3 more sources
Pulmonary Arterial Hypertension
Cardiology in Review, 2015Pulmonary arterial hypertension (PAH) is a progressive disease that remains incurable. The past 2 decades have witnessed many advances in PAH-directed therapies. More recently, 3 new oral agents have become available in the United States within the past 2 years. Treprostinil is now available in extended-release oral tablets.
Bhaumik B, Patel +2 more
openaire +2 more sources
Pulmonary Arterial Hypertension in Portal Hypertension
Clinics in Gastroenterology, 1985Frequence d'estimation difficile; hypertension pulmonaire due a la cirrhose de differentes origines ou consequence d'anastomose porto-cave. Anatomopathologie des vaisseaux pulmonaires. Nature de l'hypertension portale. Etude clinique.
openaire +2 more sources
Pulmonary Arterial Hypertension: An Overview
Seminars in Cardiothoracic and Vascular Anesthesia, 2007Pulmonary arterial hypertension (PAH) was first described over 100 years ago, but a thorough understanding of its patho-genesis and a successful approach to curing the disease remain elusive. Increased research activity has greatly enhanced our understanding of the disease and led to new therapies that retard disease progression and improve patient ...
openaire +2 more sources
Pathology of Pulmonary Arterial Hypertension
Seminars in Respiratory and Critical Care Medicine, 2009The pathological features of pulmonary arterial hypertension are highlighted in this review, which can serve as a guide to diagnosis and identification of potential cellular targets for novel lines of therapy. It also emphasizes the variability of pathological processes found in pulmonary hypertensive lungs collected by the Pulmonary Breakthrough ...
openaire +2 more sources
Phase 3 Trial of Sotatercept for Treatment of Pulmonary Arterial Hypertension
New England Journal of Medicine, 2023Marius M Hoeper +2 more
exaly
Sotatercept for the Treatment of Pulmonary Arterial Hypertension
New England Journal of Medicine, 2021J Simon R Gibbs +2 more
exaly
Treatment of Pulmonary Arterial Hypertension
New England Journal of Medicine, 2004Olivier Sitbon +2 more
exaly

